Barinthus Biotherapeutics

NASDAQ: BRNS · Real-Time Price · USD
1.13
0.03 (2.54%)
At close: Aug 20, 2025, 3:42 PM
1.14
0.88%
After-hours: Aug 20, 2025, 04:10 PM EDT

Barinthus Biotherapeutics Revenue

Barinthus Biotherapeutics reported an annual revenue of $14.97M, reflecting a 1766.46% growth. For the quarter ending March 31, 2025, Barinthus Biotherapeutics generated $0 in revenue.
Revenue (ttm)
14.97M
Revenue Growth
1766.46%
Price / Sales Ratio
3.18
Revenue / Employee
142.56K
Employees
105
Market Cap
45.59M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 14.97M +1766.46%
Dec 31, 2023 802K -98.21%
Dec 31, 2022 44.7M +16580.22%
Dec 31, 2021 268K -94.44%
Dec 31, 2020 4.82M -29.86%
Dec 31, 2019 6.87M n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.